Vanderbilt University Medical Center has been awarded a $5 million grant from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Out
Vanderbilt University Medical Center has been awarded a $5 million grant from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Out
DPP4 inhibitors a class of diabetes medications were found to be neutral with respect to cardiovascular events in veterans with no prior heart disease.
TUESDAY, May 9, 2023 (HealthDay News) There are many medications for type 2 diabetes, but one class may stand out for protecting the heart, a new study suggests.
Study authors said the findings could inform clinicians when selecting therapies for patients with type 2 diabetes (T2D). However, an editorial found the follow-up period too short and differences between the study arms too small to be meaningful.